Our Pricing

Is Ozempic the Same as Wegovy? Switch & Save with Code WEIGHTLOSSNEW

Published on: June 03, 2026

Many UK patients ask is Ozempic the same as Wegovy when exploring prescription weight loss options. Both contain semaglutide, but they're licensed for different indications, prescribed at different doses, and priced differently across UK pharmacies. Understanding these distinctions helps you make an informed choice with your prescriber.

Is Ozempic the Same as Wegovy? The Key Differences

Ozempic and Wegovy both contain the same active ingredient — semaglutide, a GLP-1 receptor agonist — but they are not interchangeable medications. Ozempic is licensed by the MHRA for type 2 diabetes management at doses up to 1mg weekly, whilst Wegovy is specifically licensed for chronic weight management at higher doses up to 2.4mg weekly [1].

The distinction matters clinically and legally. Wegovy underwent dedicated obesity trials (the STEP programme) demonstrating average weight loss of 14.9% over 68 weeks at the 2.4mg dose [1]. Ozempic's trials focused on glycaemic control in diabetic patients, though weight loss was a documented secondary outcome [2].

In the UK, prescribing Ozempic specifically for weight loss in non-diabetic patients constitutes off-label use. Your prescriber will determine which medication suits your medical history, BMI, and treatment goals during your clinical assessment.

Ozempic vs Wegovy: Dosing and Efficacy Comparison

Wegovy's dosing schedule escalates gradually from 0.25mg to a maintenance dose of 2.4mg weekly over 16-20 weeks, allowing your body to adapt and minimising gastrointestinal side effects [1]. Ozempic typically reaches a maximum of 1mg weekly for diabetes management, though some patients remain on 0.5mg depending on response [2].

Clinical trial data shows the higher semaglutide dose in Wegovy produces greater weight reduction. In the STEP 1 trial, participants on Wegovy 2.4mg lost an average of 14.9% body weight compared to 2.4% with placebo over 68 weeks [1]. Ozempic trials in diabetic patients reported average weight loss of 4.5kg at the 1mg dose [2].

Both medications work by mimicking GLP-1, a hormone that regulates appetite and blood sugar. They slow gastric emptying, increase feelings of fullness, and reduce food cravings — but the dose-dependent response means Wegovy's higher strength typically delivers more pronounced weight management results in clinical practice.

Which Semaglutide Dose Is Right for You?

Your UK prescriber will assess your BMI, existing health conditions, current medications, and weight loss goals to determine appropriate treatment. Patients with type 2 diabetes may benefit from Ozempic's dual action on blood sugar and weight, whilst those seeking weight management without diabetes are typically prescribed Wegovy subject to eligibility criteria [3].

Switching from Ozempic to Wegovy in the UK

Some patients begin with Ozempic and later transition to Wegovy for enhanced weight loss outcomes. The switch requires prescriber approval and careful dose alignment — if you're stable on Ozempic 1mg weekly, your prescriber may continue you at a comparable Wegovy dose or adjust based on your response and tolerability.

Supply considerations also influence switching decisions. Ozempic has faced intermittent UK shortages due to off-label demand for weight loss, prompting the MHRA and manufacturers to prioritise supply for diabetic patients. Wegovy, now more widely available, offers a licensed alternative specifically formulated for obesity management [3].

When switching, your prescriber will review your weight loss progress, side effect profile, and any concurrent medications. The transition is typically straightforward since both medications contain semaglutide, but individual titration may vary based on your previous dose and clinical response.

What to Expect When Switching Treatments

Most patients tolerate the switch well, particularly if moving from Ozempic 1mg to Wegovy 1.7mg or 2.4mg. Common side effects — nausea, diarrhoea, constipation — are similar across both medications and usually diminish as your body adapts. Your prescriber may recommend staying at an intermediate dose longer if you experience persistent gastrointestinal symptoms.

Wegovy Pricing and Availability at Cured Pharmacy

Wegovy is available at Cured Pharmacy from £20 offering transparent upfront pricing before you complete your free online consultation. All prescriptions are reviewed by UK-registered prescribers, and medication is dispensed by our GPhC-registered pharmacy team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

We guarantee the lowest prices in the UK and provide discreet packaging with next-day delivery options. Your consultation takes under three minutes, and our clinical team assesses your eligibility based on NICE guidance and MHRA licensing criteria for weight management treatments.

New patients can use code WEIGHTLOSSNEW at checkout for additional savings. Unlike some providers, we display final treatment costs upfront — no hidden consultation fees or surprise charges after your assessment.

Alternative Weight Loss Treatments: Mounjaro and Saxenda

If Wegovy isn't suitable or you're exploring other options, Cured Pharmacy offers additional licensed weight loss treatments including Mounjaro (tirzepatide) and Saxenda (liraglutide). Mounjaro is the UK's newest option, combining GIP and GLP-1 receptor activity for enhanced efficacy — clinical trials showed average weight loss of 22.5% at the highest dose over 72 weeks [4].

Saxenda uses liraglutide, an earlier GLP-1 medication administered as a daily injection rather than weekly. It's often prescribed for patients who prefer more frequent dosing control or have specific contraindications to semaglutide or tirzepatide. Average weight loss in trials was 8-9% over 56 weeks [5].

Your prescriber will discuss all suitable options during your consultation, considering factors like injection frequency preference, budget, previous treatment response, and any relevant medical history. All GLP-1 treatments require commitment to dietary changes and increased physical activity for optimal results.

Choosing Between Injectable Weight Loss Treatments

Mounjaro typically produces the greatest weight reduction but costs more due to its newer market entry. Wegovy offers a balance of proven efficacy and competitive pricing, whilst Saxenda suits patients preferring daily dosing or those with specific clinical considerations. Your prescriber will guide you through the evidence and help identify the most appropriate treatment for your circumstances.

How to Start Your Weight Loss Treatment at Cured Pharmacy

Beginning treatment is straightforward. Complete our free online consultation, which takes under three minutes and covers your medical history, current medications, weight loss goals, and lifestyle factors. A UK-registered prescriber reviews your responses, typically within 24 hours on working days.

If approved, your prescription is sent directly to our GPhC-registered pharmacy. We dispense only genuine UK-licensed medications and offer discreet packaging as standard. Most orders are dispatched for next-day delivery, and you'll receive tracking information once your medication is sent.

Ongoing support is included. Our clinical team is available via phone or email if you have questions about dosing, side effects, or treatment progress. Follow-up consultations ensure your treatment remains safe and effective as you work towards your weight management goals.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Davies, M., et al. (2017). Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial. JAMA, 314(7), 687–699. https://doi.org/10.1001/jama.2015.9676 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Ozempic (semaglutide): reminder of licensing indication for type 2 diabetes only. Drug Safety Update, 16(8). https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
4. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.